0001477932-24-003484.txt : 20240604 0001477932-24-003484.hdr.sgml : 20240604 20240604160605 ACCESSION NUMBER: 0001477932-24-003484 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240601 FILED AS OF DATE: 20240604 DATE AS OF CHANGE: 20240604 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Micallef Jacob Vincent CENTRAL INDEX KEY: 0001651671 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36833 FILM NUMBER: 241017957 MAIL ADDRESS: STREET 1: 1489 WEST WARM SPRINGS ROAD STREET 2: SUITE 110 CITY: HENDERSON STATE: NV ZIP: 89014 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VOLITIONRX LTD CENTRAL INDEX KEY: 0000093314 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 911949078 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1489 WEST WARM SPRINGS ROAD STREET 2: SUITE 110 CITY: HENDERSON STATE: NV ZIP: 89014 BUSINESS PHONE: 1 (646) 650-1351 MAIL ADDRESS: STREET 1: 1489 WEST WARM SPRINGS ROAD STREET 2: SUITE 110 CITY: HENDERSON STATE: NV ZIP: 89014 FORMER COMPANY: FORMER CONFORMED NAME: STANDARD CAPITAL CORP DATE OF NAME CHANGE: 19990812 4 1 form4.xml FORM 4 X0508 4 2024-06-01-05:00 false 0000093314 VOLITIONRX LTD VNRX 0001651671 Micallef Jacob Vincent 1489 WEST WARM SPRINGS ROAD SUITE 110 HENDERSON NV 89014 false true false false Chief Scientific Officer false Common Stock 2024-06-01-05:00 4 A false 40709 0 A 299224 D Common Stock 55000 I By Spouse Common Stock 38113 I By Borlaug Limited On June 1, 2024, the reporting person was awarded 40,709 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs partially vest in three installments of 13,570 units, 13,570 units, and 13,569 units on each of June 1, 2024, July 1, 2024 and August 1, 2024, respectively, are also subject to further time-based vesting in a single installment on May 1, 2025, and are generally subject to continued service throughout each applicable vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. The shares of common stock are held directly by Borlaug Limited. The reporting person is a controlling director of Borlaug Limited and has voting and dispositive control over the shares of common stock held by Borlaug Limited. /s/ Jacob Vincent Micallef 2024-06-04-05:00